2021-01-04,Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharmas Acquisition of Arvelle Therapeutics
2020-12-15,Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of  AXO-AAV-GM1 for GM1 Gangliosidosis
2020-12-02,Sio Gene Therapies Announces First Patient Dosed in High-Dose Cohort of AXO-AAV-GM1 Clinical Trial in Patients with GM1 Gangliosidosis
2020-11-19,"Sio Gene Therapies Appoints Gene Therapy Pioneer Guangping Gao, Ph.D., as Chief AAV Scientific Advisor"
2020-11-18,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axovant Gene Therapies Ltd. - AXGT
